Sotrovimab News and Research

RSS
SARS-CoV-2 Delta variant mutation sites

SARS-CoV-2 Delta variant mutation sites

Study shows neutralizing capacity of monoclonal antibodies against SARS-CoV-2 variants of concern

Study shows neutralizing capacity of monoclonal antibodies against SARS-CoV-2 variants of concern

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19